Abstract
Watch the video or view the poster to learn about:Optimum elution conditions to maximize recovery of AAV6 capsidsThe impact of pH (2.0, 2.5, and 3.0) and excipient effect (arginine, MgCl2, and propylene glycol) on AAV recoveryHigh-throughput screening and RoboColumn approachesDr Jenny England is an R&D Manager in the Application group in Purification and Pharma Analytics at Thermo Fisher Scientific. Jenny is a biophysicist by training and earned her PhD from Georgetown University. After graduate school, she did a post doc at the National Cancer Institute that focused on structure-based drug design for protein kinase complexes. Jenny currently leads the application group for process development of the POROS resin products for antibody, mRNA, plasmid, and viral vector purification. Additionally, Jenny evaluates new and emerging technologies that can be applied to solve unmet customer needs in the bioproduction workflow.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
